HBIO s Revenues Stay Flat, Earnings Shrink in Q2 | GenomeWeb

NEW YORK, July 30 (GenomeWeb News) - Harvard Bioscience yesterday reported flat revenues and dwindling earnings for the second quarter.

 

The company's revenues for the quarter totaled $22.5 million, compared to $22.4 million during the same period last year.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.